ConductScience.org, home

Paper443258

Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema.

Polese A and 3 others. Am J Med, 1979. Cited by 188 papers, by iCite.

Cite this record

ConductScience Library. Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Papers, record 443258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/443258

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema.
PubMed
Journal
Am J Med
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
188
iCite
Relative citation ratio, by iCite
10.8
iCite
Revised in PubMed
2019-06-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Polese AA
2Fiorentini CC
3Olivari MTM T
4Guazzi MDM D

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NifedipineMajor topic
Pulmonary EdemaMajor topic
PyridinesMajor topic
Adult
Aged
Blood Pressure
Calcium
Cardiomyopathies
Female
Humans
Hypertension
Male
Middle Aged
Muscle, Smooth
Myocardial Contraction
Rheumatic Heart Disease
Stroke Volume
Vascular Resistance

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 188 citations.

PMIDTitleJournalYearIn PapersSource
8097924
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8097924PubMed
7437785Unpredictable response to nifedipine in severe cardiac failure.Br Med J1980https://conductscience.org/library/papers/7437785PubMed
7427144Pulmonary oedema precipitated by nifedipine.Br Med J1980https://conductscience.org/library/papers/7427144PubMed
7272141Primary pulmonary hypertension: effects of nifedipine.Br Heart J1981https://conductscience.org/library/papers/7272141PubMed
6797645Nifedipine and beta-blockade as a cause of cardiac failure.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6797645PubMed
6713338Rebound of vasospastic angina after cessation of long-term treatment with nifedipine.Can Med Assoc J1984https://conductscience.org/library/papers/6713338PubMed
6704264Acute haemodynamic and metabolic effects of felodipine in congestive heart failure.Br Heart J1984https://conductscience.org/library/papers/6704264PubMed
6466518Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.Br Heart J1984https://conductscience.org/library/papers/6466518PubMed
6404288Coronary haemodynamic effects of nifedipine. Comparison with glyceryl trinitrate.Br Heart J1983https://conductscience.org/library/papers/6404288PubMed
6350692[Calcium antagonists in the therapy of hypertension].Klin Wochenschr1983https://conductscience.org/library/papers/6350692PubMed
6339198Calcium antagonists. Clinical use in the treatment of systemic hypertension.Drugs1983https://conductscience.org/library/papers/6339198PubMed
3784463[Calcium antagonists in heart failure?].Klin Wochenschr1986https://conductscience.org/library/papers/3784463PubMed
3542336Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.Clin Pharmacokinet1986https://conductscience.org/library/papers/3542336PubMed
3516187Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.Br Heart J1986https://conductscience.org/library/papers/3516187PubMed
3303694Treatment of severe hypertension and hypertensive crises with nifedipine.West J Med1987https://conductscience.org/library/papers/3303694PubMed
3154329Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154329PubMed
3123620Hypertensive emergencies and urgencies: definition, recognition, and management.J Gen Intern Med1988https://conductscience.org/library/papers/3123620PubMed
2874975The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.Drugs1986https://conductscience.org/library/papers/2874975PubMed
2412780Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.Drugs1985https://conductscience.org/library/papers/2412780PubMed
1720378Calcium antagonists in patients with heart failure. A review.Drugs1991https://conductscience.org/library/papers/1720378PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/443258

GET https://conductscience.org/api/papers/v1/443258/authors